Anti-MDM2 monoclonal antibody

Pre-made anti-MDM2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MDM2/MDM2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T00176-Ab-1/ GM-Tg-hg-T00176-Ab-2Anti-Human MDM2 monoclonal antibodyHuman
GM-Tg-rg-T00176-Ab-1/ GM-Tg-rg-T00176-Ab-2Anti-Rat MDM2 monoclonal antibodyRat
GM-Tg-mg-T00176-Ab-1/ GM-Tg-mg-T00176-Ab-2Anti-Mouse MDM2 monoclonal antibodyMouse
GM-Tg-cynog-T00176-Ab-1/ GM-Tg-cynog-T00176-Ab-2Anti-Cynomolgus/ Rhesus macaque MDM2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T00176-Ab-1/ GM-Tg-felg-T00176-Ab-2Anti-Feline MDM2 monoclonal antibodyFeline
GM-Tg-cang-T00176-Ab-1/ GM-Tg-cang-T00176-Ab-2Anti-Canine MDM2 monoclonal antibodyCanine
GM-Tg-bovg-T00176-Ab-1/ GM-Tg-bovg-T00176-Ab-2Anti-Bovine MDM2 monoclonal antibodyBovine
GM-Tg-equg-T00176-Ab-1/ GM-Tg-equg-T00176-Ab-2Anti-Equine MDM2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T00176-Ab-1/ GM-Tg-hg-T00176-Ab-2; GM-Tg-rg-T00176-Ab-1/ GM-Tg-rg-T00176-Ab-2;
GM-Tg-mg-T00176-Ab-1/ GM-Tg-mg-T00176-Ab-2; GM-Tg-cynog-T00176-Ab-1/ GM-Tg-cynog-T00176-Ab-2;
GM-Tg-felg-T00176-Ab-1/ GM-Tg-felg-T00176-Ab-2; GM-Tg-cang-T00176-Ab-1/ GM-Tg-cang-T00176-Ab-2;
GM-Tg-bovg-T00176-Ab-1/ GM-Tg-bovg-T00176-Ab-2; GM-Tg-equg-T00176-Ab-1/ GM-Tg-equg-T00176-Ab-2
Products NameAnti-MDM2 monoclonal antibody
Formatmab
Target NameMDM2
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MDM2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T00176-Ag-1Recombinant multi-species MDM2/ ACTFS/ HDMX protein
    ORF Viral VectorpGMLV000680human MDM2 Lentivirus plasmid
    ORF Viral VectorvGMLV000680human MDM2 Lentivirus particle
    ORF Viral VectorpGMLV000678Norway rat Mdm2 Lentivirus plasmid
    ORF Viral VectorvGMLV000678Norway rat Mdm2 Lentivirus particle


    Target information

    Target IDGM-T00176
    Target NameMDM2
    Gene ID4193,17246,314856,718284,403693,493939,540378,100052084
    Gene Symbol and Synonyms1700007J15Rik,ACTFS,edm2,hdm2,HDMX,LSKB,Mdm-2,MDM2
    Uniprot AccessionQ00987,P56950,Q7YRZ8,P56951
    Uniprot Entry NameMDM2_HUMAN,MDM2_FELCA,MDM2_CANLF,MDM2_HORSE
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseBreast Cancer
    Gene EnsemblENSG00000135679
    Target ClassificationN/A

    The target: MDM2, gene name: MDM2, also named as ACTFS, HDMX, hdm2. This gene encodes a nuclear-localized E3 ubiquitin ligase. The encoded protein can promote tumor formation by targeting tumor suppressor proteins, such as p53, for proteasomal degradation. This gene is itself transcriptionally-regulated by p53. Overexpression or amplification of this locus is detected in a variety of different cancers. There is a pseudogene for this gene on chromosome 2. Alternative splicing results in a multitude of transcript variants, many of which may be expressed only in tumor cells. [provided by RefSeq, Jun 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.